Item | Information |
---|---|
CAS RN | 50-18-0 |
Chemical Name | Cyclophosphamide anhydride |
Substance ID | m-nite-50-18-0_v1 |
Download of Excel format | Excel file |
Item | Information |
---|---|
Guidance used for the classification (External link) | To Guidance List |
UN GHS document (External link) | To UN GHS document |
FAQ(GHS classification results by the Japanese Government) | To FAQ |
List of Information Sources (Excel file) | List of Information Sources |
List of Definitions/Abbreviations | Definitions/Abbreviations |
Sample Label by MHLW (External link) | MHLW Website (in Japanese Only) |
Sample SDS by MHLW (External link) | MHLW Website (in Japanese Only) |
OECD/eChemPortal (External link) | To OECD/eChemPortal (External link) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Explosives | Not classified (Not applicable) |
- |
- | - | There are no chemical groups associated with explosive properties present in the molecules. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
2 | Flammable gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
3 | Aerosols | Not classified (Not applicable) |
- |
- | - | Not aerosol products. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
4 | Oxidizing gases | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
5 | Gases under pressure | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
6 | Flammable liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
7 | Flammable solids | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
8 | Self-reactive substances and mixtures | Not classified (Not applicable) |
- |
- | - | There are no chemical groups present in the molecule associated with explosive or self-reactive properties. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
9 | Pyrophoric liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
10 | Pyrophoric solids | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
11 | Self-heating substances and mixtures | Classification not possible |
- |
- | - | Test methods applicable to solid (melting point <= 140 degC) substances are not available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
12 | Substances and mixtures which, in contact with water, emit flammable gases | Not classified |
- |
- | - | The substance is considered to be stable against water since data are available that water solubility is 40 g/L (Merck (14th, 2006) though it contains phosphorus. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
13 | Oxidizing liquids | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
14 | Oxidizing solids | Classification not possible |
- |
- | - | Classification is not possible since no data are available though the substance is an organic compound containing oxygen which is chemically bonded to phosphorus. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
15 | Organic peroxides | Not classified (Not applicable) |
- |
- | - | Organic compounds containing no bivalent -O-O- structure | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
16 | Corrosive to metals | Classification not possible |
- |
- | - | Classification is not possible since no data are available though the substance is solid (melting point <= 55 degC). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
17 | Desensitized explosives | - |
- |
- | - | - | - | - |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
1 | Acute toxicity (Oral) | Category 3 |
Danger |
H301 | P301+P310 P264 P270 P321 P330 P405 P501 |
Based on a LD50 value of 180 mg/kg for rats (IARC 26 (1981)), the substance was classified into Category 3. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
1 | Acute toxicity (Dermal) | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
1 | Acute toxicity (Inhalation: Gases) | Not classified (Not applicable) |
- |
- | - | Solid (GHS definition) | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
1 | Acute toxicity (Inhalation: Vapours) | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
1 | Acute toxicity (Inhalation: Dusts and mists) | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
2 | Skin corrosion/irritation | Classification not possible |
- |
- | - | Classification not possible due to lack of data. Although there is a report that the substance can irritate the skin (SITTIG (5th, 2008)), the details are not clear. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
3 | Serious eye damage/eye irritation | Classification not possible |
- |
- | - | Classification not possible due to lack of data. Although there is a report that the substance can irritates the eyes and may cause severe damage (SITTIG (5th, 2008)), the details are not clear. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
4 | Respiratory sensitization | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
4 | Skin sensitization | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
5 | Germ cell mutagenicity | Category 1B |
Danger |
H340 | P308+P313 P201 P202 P280 P405 P501 |
Based on positive results in rat and mouse dominant lethal tests (in vivo heritable germ cell mutagenicity test) (IARC vol. 26 (1981)), the substance was classified into Category 1B. As relevant information, there are reports of positive chromosomal aberration tests using Chinese hamster and mouse spermatogonial (in vivo mutagenicity tests in germ cell) (IARC vol. 26 (1981)) and positive mouse and rat micronucleus tests using bone marrow and peripheral blood (in vivo somatic cell mutagenicity tests) (NTP DB (access on Oct. 2009)). For humans, it was reported that there was an increase in the number of chromosomal aberrations in the peripheral blood lymphocytes of children treated with cyclophosphamide for nonmalignant conditions. A similar effect in the peripheral blood lymphocytes was found in patients with rheumatoid arthritis following cyclophosphamide treatment. At 3 or 24-hour after an i.v. administration of cyclophosphamide, patients with recurrent ovarian or uteral carcinoma exhibited similar lymphocytes effects. Changes in bone marrow and lymph-node cells of patients with lymphogranulomatosis were observed at 24 - 72-hour after a single dose of cyclophosphamide (IARC 26 (1981)). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
6 | Carcinogenicity | Category 1A |
Danger |
H350 | P308+P313 P201 P202 P280 P405 P501 |
Based on the classification of "Group 1" in IARC (IARC 100A (2008)), the substance was classified into Category 1A. There were at least 30 case reports of malignancy (nonlymphocytic leukaemias, bladder cancers) in patients treated with the substance, and additionally the 83 cases of second malignancy (nonlymphocytic leukaemias, bladder cancers) were reported (IARC 26 (1981)). Additionally, in a rat lifetime oral administration test, it was reported that organ-specific effects on the urinary bladder were observed and bladder cancers appeared as with human (IARC 26 (1981)). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
7 | Reproductive toxicity | Category 1A, |
Danger |
H360 H362 |
P308+P313 P201 P202 P260 P263 P264 P270 P280 P405 P501 |
It was reported that cyclophosphamide can damage the germinal cells in males and females and cause sterility in people of either sex (IARC 26 (1981)). It was also reported that no big toes or their respective metatarsals and phalanges, cleft palate, no coronary artery, eye and ear malformation and multiple abnormality were observed in infants from woman treated by the substance during pregnancy (IARC 26 (1981), Birth Defects (3rd, 2000)). Therefore, the substance was classified into Category 1A. In addition, the substance was classified as "Effects on or via lactation" based on a report that the excretion into breast milk was reported (JAPIC prescription drug book (2010)). Tests in animals have shown that cyclophosphamide is teratogenic in animal species such as mice, rats and rabbits (IARC 26 (1981)). There are reports of various malformations such as ophthalmic abnormality and skeletal defects (limb, finger) in rat and mouse tests (IARC vol. 26 (1981), Birth Defects (3rd, 2000)) and cleft palate and agnathia in a rabbit test (Birth Defects (3rd, 2000)). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
8 | Specific target organ toxicity - Single exposure | Category 1 (bone marrow) |
Danger |
H370 | P308+P311 P260 P264 P270 P321 P405 P501 |
Based on a report that the substance is an antitumor drug, has significant side effects, myelosuppression (cause leukopenia and thrombocytopenia) (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (bone marrow). As relevant information, in mouse, rat and dog tests, leucopenia and depression of thrombocytes were reported (IARC 26 (1981)). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
9 | Specific target organ toxicity - Repeated exposure | Category 1 (bone marrow, heart, liver, immune system, systemic) |
Danger |
H372 | P260 P264 P270 P314 P501 |
Based on a report that the substance is an antineoplastic drug, has significant side effects, myelosuppression (cause pancytopenia, anemia, thrombocytopenia and hemorrhage) (JAPIC prescription drug book (2010)), and a report that myocardial disorder and cardiac failure occur at a frequency of 0.1 - 0.5% or less (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (bone marrow, heart). Since impaired liver function and jaundice are reported as significant side effects while the incidence is not specified (JAPIC prescription drug book (2010)), the substance was classified into Category 1 (liver). Additionally, it was reported that administration of the substance can cause anaphylactoid reaction, hemorrhagic cystitis, and oculomucocutaneous syndrome (Stevens-Johnson syndrome), however, frequencies are not specified. The substance can also cause ileus, gastrointestinal hemorrhage and interstitial pneumonia at a frequency of 0.1 - 0.5% or less (JAPIC prescription drug book (2010)). Since these symptoms are considered to involve the immune system, but the affected organ cannot be identified, the substance was classified into Category 1 (immune system, systemic toxicity). Based on all information, classification is Category 1 (bone marrow, heart, liver, immune system, systemic toxicity). | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
10 | Aspiration hazard | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
Hazard class | Classification | Pictogram Signal word |
Hazard statement (code) |
Precautionary statement (code) |
Rationale for the classification | Classification year (FY) | GHS Classification Guidance for the Japanese Government | |
---|---|---|---|---|---|---|---|---|
11 | Hazardous to the aquatic environment Short term (Acute) | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
11 | Hazardous to the aquatic environment Long term (Chronic) | Classification not possible |
- |
- | - | No data available. | FY2009 | GHS Classification Guidance by the Japanese Government (March, 2009) |
12 | Hazardous to the ozone layer | - |
- |
- | - | - | - | - |
|